3[2]Sheth SG, Gordon FD, Chopra S. Nonalcoholic steatoheptitis[J]. Ann Intern Med, 1997,126(2):137- 145.
4[3]Matthews DR, Hosker JP, Rudenski AS, et al. Homeestasis model assessment:insulin resistance and beta- cell function from fasting plasma glucose and insulin concentrations in man[J]. Diabetologia, 1985,28(7)- 419.
8[7]Marchesini G, Brizi M, Morselli- Labate AM, et al. Association of nonalcoholic fatty liver disease with insulin resistance[J] .Am J Med, 1999,107(5) :450-455.
9[8]Luyckx FH, Lefebvre PJ, Scheen AJ. Nonalcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss[J].Diabetes Metab, 2000,26:98- 106.
10[9]Pares A, Tresserras R, Nunez I, et al. Prevalence and factors associated to the presence of fatty liver in apparently health adult men[J] .Med Clin Barc, 2000,114:561-565.
5Picardi A, D'Avola D,Gentilucci UV, et al.Diabetes in chronic liver disease:from old concepts to new evidence[J].Diabetes Metab Res Rev, 2006,22(4) :274-283.
6Akbar DH, Kawther AH. Non-alcoholic fatty liver disease and metabolic syndrome:what we know and what we don't know[J]. Med Sci Monit, 2006,12(1):23-26.
7Harrison SA. Liver disease in patients with diabetes mellitus[J]. J Clin Gastroenterol, 2006,40 ( 1 ) :68-76.
8O'Connell B. Solution-Focused Therapy [ M ]. London: Sage, 1998 : 2-3.
9De Jong P, Berg IK. Interviewing for solution [ M ]. 2nd ed. Hartford : Wadsworth Group.2002:2-12.
10Toobert DJ, Hampson SE, Glasgow RE. The summary of diabetes selfcare activities measure:results from 7 studies and a revised scale[J]. Diabetes Care,2000,23(7) :943-950.
